Meningococcal bacterial DNA load at presentation correlates with disease severity

被引:110
作者
Hackett, SJ
Guiver, M
Marsh, J
Sills, JA
Thomson, APJ
Kaczmarski, EB
Hart, CA
机构
[1] Alder Hey Childrens Hosp, Inst Child Hlth, Liverpool L12 2AP, Merseyside, England
[2] Withington Hosp, MRU, Manchester M20 2LR, Lancs, England
[3] Univ Liverpool, Dept Med Microbiol, Liverpool L69 3GA, Merseyside, England
关键词
D O I
10.1136/adc.86.1.44
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aims: To determine bacterial loads in meningococcal disease (MCD), their relation with disease severity, and the factors which determine bacterial load. Methods: Meningococcal DNA quantification was performed by the Taqman PCR method on admission and sequential blood samples from patients with MCD. Disease severity was assessed using the Glasgow Septicaemia Prognostic Score (GMSPS, range 0-15, severe disease greater than or equal to 8). Results: Median admission bacterial load was 1.6 x 10(6) DNA copies/ml of blood (range 2.2 x 10(4) to 1.6 x 10(8)). Bacterial load was significantly higher in patients with severe (8.4 x 10(6)) compared to milder disease (1.1 x 10(6), p = 0.018). This difference was greater in septicaemic patients (median 1.6 x 10(7) versus 9.2 x 10(5), p < 0.001). Bacterial loads were significantly higher in patients that died to: (p = 0.017). Admission bacterial load was independent of the duration of clinical symptoms prior to admission, with no difference between the duration of symptoms in mild or severe cases (median, 10.5 and 11 hours respectively). Bacterial loads were independent of DNA elimination rates following treat ment. Conclusion: Patients with MCD have higher bacterial loads than previously determined with quantitative culture methods. Admission bacterial load is significantly higher in patients with severe disease (GMSPS greater than or equal to8) and maximum load is highest in those who die. Bacterial load is independent of the duration of clinical symptoms or the decline in DNA load.
引用
收藏
页码:44 / 46
页数:3
相关论文
共 16 条
  • [1] Evaluation of the Applied Biosystems automated Taqman polymerase chain reaction system for the detection of meningococcal DNA
    Guiver, M
    Borrow, R
    Marsh, J
    Gray, SJ
    Kaczmarski, EB
    Howells, D
    Boseley, P
    Fox, AJ
    [J]. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2000, 28 (02): : 173 - 179
  • [2] Evaluation of CMV viral load using Taqman™ CMV quantitative PCR and comparison with CMV antigenemia in heart and lung transplant recipients
    Guiver, M
    Fox, AJ
    Mutton, K
    Mogulkoc, N
    Egan, J
    [J]. TRANSPLANTATION, 2001, 71 (11) : 1609 - 1615
  • [3] Hart CA, 1997, ANN TROP MED PARASIT, V91, P777, DOI 10.1080/00034989760536
  • [4] Jefferies C, 1999, NEW ZEAL MED J, V112, P115
  • [5] Jones D., 1995, EPIDEMIOLOGY MENINGO
  • [6] An interleukin-1 genotype is associated with fatal outcome of meningococcal disease
    Read, RC
    Camp, NJ
    di Giovine, FS
    Borrow, R
    Kaczmarski, EB
    Chaudhary, AGA
    Fox, AJ
    Duff, GW
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (05) : 1557 - 1560
  • [7] Measurement of serum antigen concentration by ultrasound-enhanced immunoassay and correlation with clinical outcome in meningococcal disease
    Sobanski, MA
    Barnes, RA
    Gray, SJ
    Carr, AD
    Kaczmarski, EB
    O'Rourke, A
    Murphy, K
    Cafferkey, M
    Ellis, RW
    Pidcock, K
    Hawtin, P
    Coakley, WT
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (04) : 260 - 266
  • [8] Steven N, 1995, MENINGOCOCCAL DIS, P177
  • [9] Stuart J M, 1997, Commun Dis Rep CDR Rev, V7, pR3
  • [10] SULLIVAN TD, 1982, PEDIATRICS, V69, P699